Collagen VI-Related MyopathySymptoms, Doctors, Treatments, Advances & More
Collagen VI-Related Myopathy Overview
Learn About Collagen VI-Related Myopathy
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Paolo Bonaldo practices practicing medicine in Padova, Italy. Mr. Bonaldo is rated as an Elite expert by MediFind in the treatment of Collagen VI-Related Myopathy. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Collagen VI-Related Myopathy, Benign Autosomal Dominant Myopathy, Hyaline Fibromatosis Syndrome, and Vici Syndrome.
Francesco Muntoni practices practicing medicine in London, United Kingdom. Mr. Muntoni is rated as an Elite expert by MediFind in the treatment of Collagen VI-Related Myopathy. He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Becker Muscular Dystrophy, Duchenne Muscular Dystrophy, Primary Lateral Sclerosis, Spinal Muscular Atrophy (SMA), and Gastrostomy.
Patrizia Sabatelli practices practicing medicine in Bologna, Italy. Ms. Sabatelli is rated as an Elite expert by MediFind in the treatment of Collagen VI-Related Myopathy. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Collagen VI-Related Myopathy, Benign Autosomal Dominant Myopathy, Emery-Dreifuss Muscular Dystrophy, and X-Linked Dominant Scapuloperoneal Myopathy.
Summary: Muscular Myopathies are a heterogenous group of inherited muscular disorders characterized by progressive muscle weakness. Historically, these disorders are difficult to treat. In the last three decades, there is a great progress in molecular and genetic basis of these disorders; early diagnosis is achievable with proper clinical recognition and advanced genetic testing \[1\]. Duchenne Muscular Dy...
Summary: The Congenital Muscle Disease Patient and Proxy Reported Outcome Study (CMDPROS) is a longitudinal 10 year study to identify and trend care parameters, adverse events in the congenital muscle diseases using the Congenital Muscle Disease International Registry (CMDIR) to acquire necessary data for adverse event calculations (intake survey and medical records curation). To support this study and bec...